This announcement is a separate document:
国邦医药:国邦医药2022年半年度报告
Guobang Pharmaceutical: Guobang Pharmaceutical's 2022 Semi-Annual Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
17:35
Norwegian Ministry of Finance: The goal of the sovereign wealth fund to exit Russia still exists.
17:35
Lavrov: Russia is prepared to use any means to protect its national interests.
17:34
Norwegian Ministry of Finance: Allows the sovereign wealth fund to sell stocks of Russian companies within the scope of the current sanctions regime when opportunities arise.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.